Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Depression: Overview01:18

Depression: Overview

331
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
331
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
Long-term Depression01:03

Long-term Depression

2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

165
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
165
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

208
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
208
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

741
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
741

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Generalizable structure-function covariation predictive of antidepressant response revealed by target-oriented multimodal fusion.

Nature. Mental health·2026
Same author

Precise strategies for targeted elimination of senescent cells to combat aging and age-related diseases.

Acta biomaterialia·2026
Same author

Positive and negative affect influence learning during exposure therapy: Secondary analysis from a randomized controlled trial.

Journal of anxiety disorders·2026
Same author

"Doing Our Best:" A Qualitative Study of Researcher Challenges Administering Neuromodulation Across Different Phenotypes.

AJOB neuroscience·2026
Same author

Personalized Network-Guided Neuromodulation Enhances Human Working Memory.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Dual Mechanisms of crRNA 3'-Extension-Mediated Cas12a Attenuation Enable Programmable One-Pot CRISPR Diagnostics.

Analytical chemistry·2026

Video Experimental Relacionado

Updated: Sep 9, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

174

Cambios cerebrales asociados con el tratamiento de la depresión: un metanálisis

Gianna M Perez1, Benjamin M Rosenberg2, Wenyi Xu3

  • 1Center for Brain Imaging and Stimulation, Center for Neuromodulation in Depression and Stress Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

NeuroImage. Clinical
|August 31, 2025
PubMed
Resumen

El tratamiento eficaz para la depresión reduce constantemente la actividad en la amígdala derecha, una región clave del cerebro identificada a través de la neuroimagen. Este hallazgo ayuda en el desarrollo de biomarcadores para el seguimiento del progreso del tratamiento en el trastorno depresivo mayor.

Palabras clave:
Las amígdalasLos biomarcadoresLa depresiónTratamiento de la depresiónMeta-análisisResonancia magnética funcional

Más Videos Relacionados

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

791
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.7K

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

174
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

791
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.7K

Área de la Ciencia:

  • Imágenes neurológicas
  • Investigación psiquiátrica
  • Actividad cerebral

Sus antecedentes:

  • Comprender los cambios cerebrales después del tratamiento es crucial para avanzar en la neuroimagen en psiquiatría.
  • La investigación se ha centrado principalmente en las diferencias entre el paciente y el control, con menos énfasis en los cambios dentro del paciente después del tratamiento de la depresión.
  • Este estudio sintetiza los hallazgos de diversos tratamientos para identificar mecanismos neuronales comunes.

Objetivo del estudio:

  • Para llevar a cabo un meta-análisis basado en coordenadas de los estudios de tratamiento de la depresión.
  • Identificar regiones cerebrales comunes que muestran actividad alterada antes y después del tratamiento.
  • Explorar mecanismos de tratamiento compartidos en varias intervenciones terapéuticas para la depresión.

Principales métodos:

  • Se utilizó la estimación de la probabilidad de activación (ALE) para el metanálisis.
  • Se incluyeron datos de 302 sujetos en 18 experimentos.
  • Datos de resonancia magnética funcional basados en tareas sintetizadas de estudios que incluyen farmacología, psicoterapia, ECT, psilocibina y ketamina.

Principales resultados:

  • Identificó la amígdala derecha como una región consistente de cambio convergente en todos los estudios.
  • Las coordenadas máximas de la INM para la amígdala derecha se encuentran en [30, 2, -22].
  • Se encontró que la disminución de la actividad en la amígdala derecha se asoció con el tratamiento eficaz de la depresión.

Conclusiones:

  • Destaca la importancia de la amígdala derecha en la respuesta al tratamiento de la depresión medida por fMRI.
  • Sugiere la amígdala derecha como un potencial biomarcador de imágenes para el seguimiento de los efectos del tratamiento.
  • Proporciona un área enfocada para futuras investigaciones de biomarcadores de depresión basadas en neuroimágenes.